Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Peptic ulcer disease".)

Canada

●Canadian Association of Gastroenterology (CAG): Canadian consensus guidelines on long-term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection – Benefits versus risks (2009)

United States

●American College of Gastroenterology (ACG): Practice guidelines for the management of patients with ulcer bleeding (2012)

●American College of Cardiology Foundation (ACCF)/ACG/American Heart Association (AHA): Expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines – A focused update on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use (2010)

●ACG: Guidelines for prevention of NSAID-related ulcer complications (2009)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Clinical guideline on gastro-oesophageal reflux disease and dyspepsia in adults – Investigation and management (2014, updated 2019)

●NICE: Clinical guideline on acute upper gastrointestinal bleeding in over 16s – Management (2012, updated 2016)

Australia-New Zealand

●Choosing Wisely Australia: Don't recommend the regular use of oral non-steroidal anti-inflammatory medicines (NSAIDs) in older people

Japan

●The Japanese Society of Gastroenterology (JSGE): Evidence-based clinical practice guidelines for peptic ulcer disease, 2015 (published 2016)